These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Indications for long-term neuroleptic medication--standard procedure or individual prognosis-guided intervention? A prospective study of the clinical treatment model]. Gaebel W, Pietzcker A. Nervenarzt; 1983 Sep; 54(9):467-76. PubMed ID: 6138719 [No Abstract] [Full Text] [Related]
28. Evaluation of piperacetazine (Quide) injection in acute schizophrenics. Kiev A, Güclü B, Kulkarni AS. Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517 [No Abstract] [Full Text] [Related]
29. Subjective response to neuroleptics: the effect of a questionnaire about neuroleptic side effects. Taira M, Hashimoto T, Takamatsu T, Maeda K. Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug 30; 30(6):1139-42. PubMed ID: 16765499 [Abstract] [Full Text] [Related]
30. [Drug management and therapy resistance. A cross-sectional study of schizophrenic patients in a large psychiatric hospital]. Mohr F, Bender W, Hubmann W, Mäsel K, Pior R. Psychiatr Prax; 1992 Jul 30; 19(4):108-13. PubMed ID: 1354878 [Abstract] [Full Text] [Related]
31. Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients. van Berckel BN, Hijman R, van der Linden JA, Westenberg HG, van Ree JM, Kahn RS. Biol Psychiatry; 1996 Dec 15; 40(12):1298-300. PubMed ID: 8959296 [No Abstract] [Full Text] [Related]
32. [What should we recommend for schizophrenic patients: long-term drug prevention or interval treatment?]. Müller P. Nervenarzt; 1983 Sep 15; 54(9):477-85. PubMed ID: 6138720 [No Abstract] [Full Text] [Related]
34. The choice of neuroleptics in the treatment of schizophrenia: a critical review. Tansella M, Balestrieri A. Arzneimittelforschung; 1976 Sep 15; 26(5):943-5. PubMed ID: 9102 [Abstract] [Full Text] [Related]
35. A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia. Salimi S, Fotouhi A, Ghoreishi A, Derakhshan MK, Khodaie-Ardakani MR, Mohammadi MR, Noorbala AA, Ahmadi-Abhari SA, Hajiazim M, Abbasi SH, Akhondzadeh S. Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):726-32. PubMed ID: 18096287 [Abstract] [Full Text] [Related]
38. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J. Clin Ther; 2008 Dec 01; 30(12):2378-86. PubMed ID: 19167596 [Abstract] [Full Text] [Related]
39. Déjà vu experiences in schizophrenia: relations with psychopathology and antipsychotic medication. Adachi N, Adachi T, Akanuma N, Matsubara R, Ito M, Takekawa Y, Ikeda H, Arai H. Compr Psychiatry; 2007 Dec 01; 48(6):592-6. PubMed ID: 17954146 [Abstract] [Full Text] [Related]
40. Collaboration in outpatient antipsychotic drug treatment: analysis of potentially influencing factors. Klingberg S, Schneider S, Wittorf A, Buchkremer G, Wiedemann G. Psychiatry Res; 2008 Nov 30; 161(2):225-34. PubMed ID: 18922582 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]